MENA Pharmaceutical Supplier

Fourteen Markets,
One UK Wholesale Licence.

Euro Biom is the MHRA WDA(H) 59239 licensed UK pharmaceutical supplier covering the full Middle East and North Africa corridor. Gulf high-spec hospital networks, Levant shortage and conflict supply, Turkey TITCK pathways, and the North African regulator chain. One Heathrow source, one chain of custody, fourteen regulatory languages, one accountable wholesaler.

Request a MENA Quote Download Company Profile Same-day response, every Mediterranean and Gulf enquiry.
Region 1 / GCC
🇸🇦 🇦🇪 🇶🇦 🇰🇼 🇧🇭 🇴🇲
Gulf Cooperation Council
6 markets, 7+ regulators
Region 2 / Levant & Turkey
🇱🇧 🇯🇴 🇮🇶 🇹🇷
Eastern Mediterranean
4 markets, complex shortages
Region 3 / North Africa
🇪🇬 🇲🇦 🇩🇿 🇸🇩
Maghreb & Nile Corridor
4 markets, French & Arabic
14
MENA markets with active supply
12+
National regulators in our documentation library
3
Working languages: English, Arabic, French
WDA(H)
59239 MHRA Wholesale Dealer Authorisation
Why UK to MENA Works

One Wholesale Source Across a Fragmented Region.

The Middle East and North Africa is not one market. It is a corridor of fourteen national regulators, three working languages, four currency regimes, two trade blocs (GCC and Maghreb), and a humanitarian operating layer that overlays the commercial one. Hospital procurement teams that try to assemble a UK supply chain country by country end up with fourteen contracts, fourteen quality dossiers and fourteen failure points.

Euro Biom collapses that to one. We are the single MHRA-licensed UK wholesaler on the contract. The product, the chain of custody and the GDP records are constant. What changes is the regulator overlay we apply on top, SFDA, DHA, MOHAP, MOPH, KDFCA, NHRA, JFDA, MoPH Lebanon, Kimadia, TITCK, EDA, DMP, LNCPP, NMPB, configured per shipment.

For procurement teams running cross-MENA programmes, that means one supplier qualification audit, one set of WDA records, and one named MHRA Responsible Person to escalate to. For hospitals running country-specific cases, it means the same speed and document quality regardless of whether the patient is in Riyadh, Beirut, Istanbul or Casablanca.

Regulators in Our MENA Library

Country-specific dossier overlays prepared in-house. Documents are notarised, apostilled or consular-attested through the relevant embassy in London where required.

Saudi Arabia
SFDA / NUPCO
UAE
DHA / MOHAP / DOH
Qatar
MOPH
Kuwait
KDFCA
Bahrain
NHRA
Oman
MOH Oman
Jordan
JFDA
Lebanon
MoPH Lebanon
Iraq
Kimadia / KRG-MoH
Turkey
TITCK
Egypt
EDA
Morocco
DMP
Algeria
LNCPP
Sudan
NMPB / Humanitarian
Markets We Supply
Fourteen MENA Markets, Grouped by Sub-Region.

Each sub-region has its own procurement reality. The GCC core moves on regulator-led tenders and licensed importers. The Levant blends private hospital procurement with humanitarian flows. North Africa runs on French-language dossiers and centralised public procurement.

01

The GCC Core

6 markets · high-income · tender + private hospital
🇸🇦
Saudi Arabia
Largest GCC Market
SFDA-registered importers, NUPCO tender programmes and tertiary hospitals including KFSH-RC and KFMC. Specialist oncology, biologics and named patient lines under Vision 2030 healthcare expansion.
RiyadhSFDA
Saudi supply details →
🇦🇪
United Arab Emirates
Three-Regulator Market
DHA in Dubai, MOHAP federally and DOH in Abu Dhabi. We supply DHCC clinics, SEHA, Cleveland Clinic Abu Dhabi and licensed importers across all seven emirates.
DubaiDHA / MOHAP
UAE supply details →
🇶🇦
Qatar
~97% Import Dependent
High-spec public health network anchored by Hamad Medical Corporation and Sidra Medicine. We supply Ebn Sina-listed importers and HMC procurement with MOPH-aligned dossiers.
DohaMOPH
Qatar supply details →
🇰🇼
Kuwait
Local Agent Required
KDFCA-regulated market with mandatory licensed local agent. We work through YIACO Medical and other established Kuwaiti agents into MoH hospitals and Central Tenders Committee programmes.
Kuwait CityKDFCA
Kuwait supply details →
🇧🇭
Bahrain
Causeway Logistics
NHRA-regulated imports with King Fahd Causeway logistics into Saudi Eastern Province. We supply BDF Hospital, Salmaniya Medical Complex and KHUH with branded specials and shortage lines.
ManamaNHRA
Bahrain supply details →
🇴🇲
Oman
Vision 2040 Healthcare
SQUH and Royal Hospital anchor the public network, supported by an MOH-led drug policy committed to expanded specialist access. We supply Muscat-based importers with named patient and shortage lines.
MuscatMOH Oman
Oman supply details →
02

Levant & Turkey

4 markets · shortage-driven · humanitarian overlay
🇱🇧
Lebanon
Banking & Shortage Crisis
UK-sourced medicines into a market reshaped by banking and currency conditions. We supply AUBMC, Hotel-Dieu de France, Rafic Hariri University Hospital and private importers with oncology, cardiovascular and paediatric lines.
BeirutMoPH Lebanon
Lebanon supply details →
🇯🇴
Jordan
Regional Medical Hub
Regional medical hub serving Jordanian, Iraqi and refugee populations. We supply King Hussein Cancer Center, Jordan University Hospital, Abdali Hospital and UNRWA-linked programmes with biologics and orphan medicines.
AmmanJFDA
Jordan supply details →
🇮🇶
Iraq
Federal + Kurdistan Region
Federal Iraq plus Kurdistan Region supply. We support Kimadia tenders, Baghdad Medical City, Basra Teaching Hospital and Erbil Teaching Hospital with oncology biologics and specialist lines for the new cancer centres.
BaghdadKimadia
Iraq supply details →
🇹🇷
Turkey
85M Population, Sophisticated
Large sophisticated market with significant demand for specialist UK-sourced medicines. We supply Bilkent City Hospital, Hacettepe, university hospitals and specialty pharma distributors with branded, unlicensed and shortage products.
IstanbulTITCK
Turkey supply details →
03

North Africa

4 markets · French & Arabic · central public procurement
🇪🇬
Egypt
Largest North Africa Market
North Africa's largest pharmaceutical market by volume. We supply Cairo and Alexandria-based importers, Kasr El Aini, university hospitals and government programmes with EDA-aligned dossiers for specialist and shortage lines.
CairoEDA
Egypt supply details →
🇲🇦
Morocco
Francophone Maghreb
Growing pharmaceutical market with Francophone regulatory framework. We supply CHU Ibn Sina, university hospitals, importers and health programmes in Casablanca and Rabat with French-language DMP-aligned dossiers.
CasablancaDMP
Morocco supply details →
🇩🇿
Algeria
Centralised Public Procurement
One of North Africa's largest pharmaceutical markets. We supply CHU Mustapha Bacha, CHU Oran, licensed importers and private sector buyers with oncology, biologic and specialist products backed by LNCPP-ready documentation.
AlgiersLNCPP
Algeria supply details →
🇸🇩
Sudan
Humanitarian Priority
Humanitarian-led pharmaceutical supply into Port Sudan, Khartoum and field regions. We work with MSF, ICRC, UNICEF and WHO-partnered programmes providing IEHK-compatible kits and NMPB documentation.
Port SudanNGO Supply
Sudan supply details →
What Cross-MENA Procurement Hits
Six Frictions That Trip Up Multi-Country Supply.

A case that lands in Riyadh smoothly may stall in Algiers, and a Lebanon shortage line needs a different supplier posture from a Qatar tender. These are the six points where multi-MENA procurement most often fails, and what we have built to solve each.

Twelve regulators, twelve dossier shapes

SFDA, DHA, MOHAP, MOPH, KDFCA, NHRA, JFDA, MoPH Lebanon, Kimadia, TITCK, EDA, DMP, LNCPP, NMPB. Each has its own preferred document order, attestation route and language. We hold templates and a London-based notarisation flow for all of them.

Three working languages

English for the Gulf and Egyptian streams, French for Maghreb (Morocco, Algeria) and the older Levant dossiers, Turkish for TITCK. Certified translation handled in London, original English MHRA documents always retained.

Cold chain through 50 degree summers

Standard freight cold chain is rated for European ambient. Gulf and North African tarmac sits at 45 to 50 degrees in summer. Pre-conditioned PCM, validated shippers and direct routing engineered for the heat profile, not assumed.

Speed gap between markets

A Gulf same-day quote does not survive the trip into a Levant or North African workflow if the supplier is not set up for it. We commit to same-working-day response across all 14 markets, with a single named export desk owning your case.

Currency and payment conditions

Lebanon, Egypt and Sudan supply often runs through diaspora-supported, NGO-routed or donor-funded payment structures rather than standard commercial terms. We are set up to invoice into those flows compliantly without breaking GDP custody.

Humanitarian and NGO overlays

Sudan, parts of Iraq and Lebanon-based programmes operate through MSF, ICRC, UNICEF and WHO-aligned channels rather than standard hospital procurement. IEHK-compatible kits, donor traceability and NGO audit-ready records, all on top of MHRA WDA baseline.

What We Supply Across MENA
Four Service Lines, Tuned for the Region.

The product we ship is the same MHRA-licensed UK pharmaceutical that any qualified buyer would expect. What changes country to country is the service shape around it.

Service 01

Named Patient & Special Import

UK-sourced medicines for individual patients across MENA hospitals where the product is unregistered locally, unavailable through standard distribution, or required under a regulator-approved compassionate use or special import framework.

  • SFDA, DHA, MOHAP, MOPH, KDFCA, NHRA, JFDA pathways
  • EDA, DMP, LNCPP, TITCK and Lebanese MoPH overlays
  • CPP plus MHRA supporting documentation
  • Same-day quote and availability confirmation
Service 02

Drug Shortage & Hospital Continuity

When standard regional distribution fails, MENA hospitals reach upstream. Lebanon shortage cases, Egyptian dollar-shortage gaps, GCC tender failures and Maghreb supply interruptions, all met with UK-licensed alternatives and 24-hour dispatch on in-stock lines.

  • UK-licensed branded and generic equivalents
  • Validated cold chain to plus 50 degree ambient
  • Direct Heathrow freight to all 14 MENA capitals
  • Out-of-hours response on critical care lines
Service 03

Tender, Hospital & Government Procurement

Tender-ready supplier qualification across MENA public sector procurement. NUPCO, KCTC, MOPH Qatar, Kimadia, JFDA frameworks, Egyptian UPA, Algerian PCH, Moroccan public procurement and the Turkish state hospital network.

  • Locked pricing held through tender windows
  • WDA, GDP and MHRA Responsible Person dossiers
  • Local agent coordination per market
  • Long-term contract supply with batch consistency
Service 04

NGO, Humanitarian & Cold Chain Export

For Sudan, Iraq and Lebanon-based humanitarian programmes, we work alongside MSF, ICRC, UNICEF and WHO-aligned channels. IEHK-compatible kits, donor traceability and humanitarian payment routing, all under MHRA WDA baseline plus validated cold chain to extreme ambient.

  • MSF, ICRC, UNICEF, WHO-aligned supply
  • IEHK-compatible kit configuration
  • Validated 2 to 8 degree and minus 20 degree shippers
  • Donor and NGO audit-ready records
How a MENA Order Moves
From Enquiry to Hospital Pharmacy in Four Steps.

A typical MENA case follows this shape. Tender bids run longer at the front end, humanitarian flows substitute donor approval for hospital approval, but the backbone is consistent.

1

Enquiry

MENA importer, hospital pharmacist, NGO procurement lead or distributor submits product list, quantities, target country, regulator overlay and any patient or tender reference.

Minute zero
2

Quote & Availability

We confirm UK source, batch availability, cold chain rating, country-specific overlay needed, locked price (or donor-routed terms) and earliest dispatch slot.

Same working day
3

Documentation & Translation

CPP, CFS, GMP, CoA, batch release, GDP chain of custody, regulator-specific overlay and Arabic / French / Turkish translation assembled in parallel with importer-side approval.

24 to 96 hours
4

Dispatch & Tracking

Validated shipper sealed, direct Heathrow flight booked, dual data loggers active, importer or NGO partner notified with AWB, live ETA and customs clearance support.

5 to 12 working days
MENA Frequently Asked Questions
What Procurement Teams Across the Region Ask Us.
What is the difference between GCC supply and MENA supply?
GCC supply is a subset of MENA supply. The Gulf Cooperation Council covers six high-income markets (Saudi Arabia, the UAE, Qatar, Kuwait, Bahrain and Oman) where regulators are well-resourced and procurement concentrates through national health systems and licensed importers. MENA, the wider Middle East and North Africa, adds the Levant (Lebanon, Jordan, Iraq), Turkey and the North African corridor (Egypt, Morocco, Algeria, Sudan). MENA supply means engaging with a far wider range of regulators, languages, currency conditions and humanitarian structures, on top of the Gulf core. If your sourcing programme is GCC-only, our GCC pillar page is the right entry point. If it is multi-country across the wider region, this page is.
Which MENA countries does Euro Biom serve?
Euro Biom currently exports to 14 MENA markets. The GCC core (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman), the Levant (Lebanon under MoPH, Jordan under JFDA, Federal Iraq plus the Kurdistan Region under Kimadia and KRG-MoH), Turkey under TITCK, and four North African markets (Egypt under EDA, Morocco under DMP, Algeria under LNCPP, and Sudan under NMPB and through humanitarian channels). Each market has its own dedicated supply page reachable from the country grid above.
How does Brexit affect UK to MENA pharmaceutical supply?
For most MENA countries the UK exit from the EU has been a net positive. UK MHRA documentation, Wholesale Dealer Authorisation (WDA) and Good Distribution Practice (GDP) records remain fully recognised by SFDA, DHA, MOHAP, MOPH, KDFCA, NHRA, JFDA, MoPH Lebanon, EDA, DMP, LNCPP and others. The MHRA continues to issue Certificates of Pharmaceutical Product on the WHO format that MENA importers expect. The main practical change is that some shortage-driven flows that previously moved EU to MENA now route via the UK, which adds opportunity rather than friction for UK-licensed suppliers.
Can Euro Biom support tender bidding in MENA markets?
Yes. Euro Biom provides locked tender pricing, supplier qualification dossiers and the full export documentation pack for institutional procurement across MENA. That includes NUPCO in Saudi Arabia, Kuwait Central Tenders Committee, MOPH Qatar frameworks, MOH Bahrain, MOH Oman, Kimadia in Iraq, JFDA frameworks in Jordan, Egyptian UPA tenders, and Algerian PCH and CHU programmes. We work through licensed local agents who hold the relevant in-country licences and direct relationships with the procurement bodies.
What about humanitarian and NGO pharmaceutical supply in MENA?
Conflict-affected and humanitarian-priority MENA markets are a routine part of our work. Sudan is currently supplied primarily through humanitarian partnerships with MSF, ICRC, UNICEF and WHO-aligned programmes, with IEHK-compatible kit configuration and NMPB documentation. Iraq supply blends federal Kimadia tenders with NGO-led programmes in the Kurdistan Region. Lebanon supply navigates banking and currency conditions that make standard commercial terms difficult, often working through NGO and diaspora-supported hospital procurement. Across all of these, our MHRA WDA and GDP records provide the upstream regulatory baseline that humanitarian buyers require.
What languages of documentation does Euro Biom provide for MENA imports?
Core MHRA-issued documentation is provided in English, which is accepted across MENA regulators including SFDA, DHA, MOHAP, MOPH, KDFCA, NHRA, JFDA, EDA, DMP and TITCK. We additionally support certified Arabic translation for hospital records, tender forms and Levant or North African ministry overlays where required, French translation for Maghreb markets (Morocco, Algeria) and the older Egyptian dossier streams, and Turkish translation for TITCK submissions. Original English documents are always retained for regulatory traceability.
How is Euro Biom different from a generalist UK exporter quoting MENA?
Euro Biom is an MHRA-licensed wholesale dealer (WDA(H) 59239), not a broker. Every MENA consignment leaves a UK GDP-compliant facility under our own WDA licence, with documented chain of custody from licensed UK source to MENA importer or NGO partner. Brokers route through unverified intermediaries, frequently cannot issue compliant CPPs, and create traceability gaps that MENA regulators are increasingly auditing for. That regulatory difference matters most on high-value oncology, biologics, shortage lines and humanitarian consignments, where audit defensibility is part of the contract.

Sourcing UK medicines across MENA? Start with one supplier.

Tell us the markets, the products and the documentation overlay. We will respond on the same working day with availability, locked pricing and the regulator dossiers configured for each country.